Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of "benign autoimmunity "to the concept of" autoimmunity as a red flag in preventive medicine"?

Autoimmun Rev. 2018 Jun;17(6):636-638. doi: 10.1016/j.autrev.2018.01.013. Epub 2018 Apr 8.
No abstract available

Keywords: Antinuclear antibodies; Cardiovascular disease; Interstitial lung disease; Mortality; Peripheral venous thrombosis; Rheumatoid factor.

Publication types

  • Letter